杨氏透穴疗法治疗气滞血瘀证颈源性头痛临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R741

基金项目:

衢州市科技计划项目(2021081)


Clinical Study on Yang's Point Penetration Therapy for Cervicogenic Headache with Qi Stagnation and Blood Stasis Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察杨氏透穴疗法治疗气滞血瘀证颈源性头痛的临床疗效。方法:选择2022 年9 月— 2023年9月衢州市中医医院收治的104例颈源性头痛患者,按照随机数字表法分为对照组、试验组各52例。其 中对照组有3例被剔除、1例失访,最终纳入48例;试验组有2例被剔除、1例主动退出,最终纳入49例。对 照组口服塞来昔布胶囊,试验组在对照组基础上给予杨氏透穴疗法。治疗4周后,观察2组临床疗效、疼痛情 况[视觉模拟评分法(VAS) 评分、每天头痛持续时间]、颈椎活动功能评分、中医证候评分、睡眠质量 [匹兹堡睡眠质量指数量表(PSQI)]、生活质量[SF-36生活质量调查表(SF-36)] 和安全性。结果:试验 组总有效率为93.88% (46/49),对照组为79.17% (38/48),2组比较,差异有统计学意义(P<0.05)。治疗 后,2组疼痛VAS评分、每天头痛持续时间较均治疗前减少(P<0.05),且试验组疼痛VAS评分、每天头痛持 续时间均少于对照组(P<0.05)。治疗后,2组颈部活动功能评分、中医证候评分、PSQI评分均较治疗前降 低(P<0.05),且试验组3 项评分均低于对照组(P<0.05)。治疗后,2 组SF-36 评分较治疗前升高(P< 0.05),且试验组SF-36评分高于对照组(P<0.05)。治疗期间,2组患者均未出现严重不良事件。结论:杨氏 透穴疗法治疗气滞血瘀证颈源性头痛效果良好,可减轻头痛程度和颈椎活动度,改善患者生活质量和睡眠 质量。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Yang's point penetration therapy on cervicogenic headache with qi stagnation and blood stasis syndrome. Methods:A total of 104 patients with cervicogenic headache admitted to Quzhou Hospital of Traditional Chinese Medicine from September 2022 to September 2023 were randomly divided into the control group and the trial group, with 52 patients in each group, using a random number table method. Among them,three cases were excluded and one case was lost to follow-up in the control group,and ultimately 48 cases were included;two cases were excluded from the trial group,one case voluntarily withdrew,and ultimately 49 patients were included. The control group received oral Celecoxib Capsules,while the trial group received Yang's point penetration therapy on the basis of the control group. After four weeks of treatment, the clinical efficacy, pain status [Visual Analogue Scale (VAS) scores, and daily headache duration], cervical functional scores, traditional Chinese medicine(TCM) syndrome scores,sleep quality [Pittsburgh Sleep Quality Index (PSQI)],quality of life [Short-From 36 Health Surve (SF-36)], and safety were observed in the two groups. Results: The total effective rate was 93.88% (46/49) in the trial group, and 79.17% (38/48) in the control group, the difference being significant (P< 0.05). After treatment, the VAS scores of pain and daily headahe duration in both groups were decreased when compared with those before treatment (P<0.05),and the VAS score of pain and daily headache duration in the trial group were lower than those in the control group (P<0.05). After treatment,the cervical spine functional scores,TCM syndrome scores and PSQI scores in both groups were decreased when compared with those before treatment (P<0.05), and the scores of three items in the trial group were lower than those in the control group (P<0.05). After treatment, the SF-36 scores in both groups were increased when compared with those before treatment (P<0.05),and the SF-36 score in the trial group was higher than that in the control group (P<0.05). During the treatment period,neither group of patients experienced any serious adverse events. Conclusion:Yang's point penetration therapy has a good effect on treating cervicogenic headache caused by qi stagnation and blood stasis syndrome, which can reduce the severity of headache,improve the cervical activity function,quality of life,and sleep quality of patients.

    参考文献
    相似文献
    引证文献
引用本文

王爱君,金瑛,谢蔚,付桃芳.杨氏透穴疗法治疗气滞血瘀证颈源性头痛临床研究[J].新中医,2025,57(6):81-85

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-03-26
  • 出版日期:
文章二维码